US Stock MarketDetailed Quotes
CARM Carisma Therapeutics
- 0.845
- +0.023+2.76%
Close Nov 25 16:00 ET
35.29MMarket Cap-553P/E (TTM)
0.889High0.830Low226.48KVolume0.833Open0.823Pre Close194.11KTurnover1.01%Turnover RatioLossP/E (Static)41.75MShares3.16052wk High-3.18P/B19.03MFloat Cap0.80052wk Low--Dividend TTM22.51MShs Float51.357Historical High--Div YieldTTM7.14%Amplitude0.800Historical Low0.857Avg Price1Lot Size
Carisma Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -11.55%3.39M | 158.34%9.2M | 4.75%3.4M | 51.71%14.92M | 14.96%4.29M | 48.45%3.83M | 31.71%3.56M | 294.53%3.24M | 9.83M | 3.73M |
| Operating revenue | -11.55%3.39M | 158.34%9.2M | 4.75%3.4M | 51.71%14.92M | 14.96%4.29M | 48.45%3.83M | 31.71%3.56M | 294.53%3.24M | --9.83M | --3.73M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -36.84%16.53M | -14.92%20.87M | -12.62%22.91M | 57.05%103.65M | 40.34%26.74M | 35.40%26.17M | 47.42%24.53M | 138.80%26.22M | 61.78%66M | 19.05M |
| Selling and administrative expenses | -21.40%5.2M | -7.44%5.56M | -43.13%5.45M | 214.83%29.53M | 654.27%7.32M | 75.50%6.62M | 147.81%6.01M | 333.02%9.57M | 46.37%9.38M | --971K |
| -General and administrative expense | -21.40%5.2M | -7.44%5.56M | -43.13%5.45M | 214.83%29.53M | 654.27%7.32M | 75.50%6.62M | 147.81%6.01M | 333.02%9.57M | 46.37%9.38M | --971K |
| Research and development costs | -42.07%11.33M | -17.34%15.31M | 4.93%17.46M | 30.92%74.13M | 7.37%19.42M | 25.67%19.55M | 30.30%18.52M | 89.81%16.64M | 64.65%56.62M | --18.08M |
| Operating profit | 41.17%-13.14M | 44.34%-11.67M | 15.07%-19.51M | -57.99%-88.73M | -46.52%-22.45M | -33.39%-22.34M | -50.47%-20.97M | -126.19%-22.97M | -37.67%-56.16M | -15.32M |
| Net non-operating interest income expense | -53.03%442K | -56.84%508K | 136.02%532K | 161.56%1.94M | 249.37%1.3M | 203.63%941K | 252.66%1.18M | -146.58%-1.48M | -31,550.00%-3.15M | -867K |
| Non-operating interest income | ---- | ---- | ---- | --1.94M | ---- | ---- | ---- | ---- | ---- | ---- |
| Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.15M | ---- |
| Total other finance cost | 53.03%-442K | 56.84%-508K | -136.02%-532K | ---- | ---- | -203.63%-941K | -252.66%-1.18M | 146.58%1.48M | ---- | ---- |
| Other net income (expense) | 95.62%-84K | 0 | 84.92%-84K | -1.92M | -550K | |||||
| Gain on sale of security | ---- | ---- | ---- | 95.62%-84K | --0 | ---- | ---- | 84.92%-84K | ---1.92M | ---550K |
| Income before tax | 40.65%-12.7M | 43.59%-11.16M | 22.64%-18.98M | -41.90%-86.88M | -26.38%-21.16M | -16.78%-21.4M | -33.27%-19.79M | -116.88%-24.53M | -50.12%-61.23M | -16.74M |
| Income tax | 0 | 0 | 0 | 0 | 88K | 109K | ||||
| Net income | 40.65%-12.7M | 43.84%-11.16M | 22.99%-18.98M | -41.90%-86.88M | -25.20%-20.96M | -16.78%-21.4M | -33.86%-19.88M | -117.84%-24.64M | -50.12%-61.23M | -16.74M |
| Net income continuous Operations | 40.65%-12.7M | 43.84%-11.16M | 22.99%-18.98M | -41.90%-86.88M | -25.20%-20.96M | -16.78%-21.4M | -33.86%-19.88M | -117.84%-24.64M | -50.12%-61.23M | ---16.74M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 40.65%-12.7M | 43.84%-11.16M | 22.99%-18.98M | -41.90%-86.88M | -25.20%-20.96M | -16.78%-21.4M | -33.86%-19.88M | -117.84%-24.64M | -50.12%-61.23M | -16.74M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 40.65%-12.7M | 43.84%-11.16M | 22.99%-18.98M | -41.90%-86.88M | -25.20%-20.96M | -16.78%-21.4M | -33.86%-19.88M | -117.84%-24.64M | -50.12%-61.23M | -16.74M |
| Basic earnings per share | 41.51%-0.31 | 44.90%-0.27 | 76.17%-0.46 | -70.29%-2.59 | -15.43%-0.48 | -16.41%-0.53 | -32.84%-0.49 | -586.81%-1.93 | -50.12%-1.521 | -0.4158 |
| Diluted earnings per share | 41.51%-0.31 | 44.90%-0.27 | 76.17%-0.46 | -70.29%-2.59 | -15.43%-0.48 | -16.41%-0.53 | -32.84%-0.49 | -586.81%-1.93 | -50.12%-1.521 | -0.4158 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data